ABCAM Plc (ABC) - Total Voting Rights RNS Number : 1549Q ABCAM Plc 01 November 2012 For immediate release 1 November 2012 ABCAM PLC ("Abcam" or "the Company") Total Voting Rights - Voting Rights and Capital In conformity with5.6.1 oftheDisclosure andTransparencyRules,the Companynotifies the market of the following: TheCompany's issued share capital consists of198,396,519 Ordinary Shares of0.2p each with voting rights. The Company does not hold any shares in Treasury. The above figure of198,396,519 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest inthe Companyunder the FSA's Disclosure and Transparency Rules. Dateof Notification: 1 November 2012 For further information please contact: Abcam + 44 (0) 1223 696 000 Jeff Iliffe, Chief Financial Officer Numis Securities - Nominated Adviser & Joint Broker + 44 (0) 20 7260 1000 Michael Meade - Nominated Adviser James Black - Corporate Broking Peel Hunt LLP - Joint Broker + 44 (0) 20 7418 8900 Andy Crossley - Corporate Broking Buchanan + 44 (0) 20 7466 5000 Mark Court / Fiona Henson / Sophie Cowles Notes for editors: About Abcam plc Abcam is a producer and distributor of high quality protein research tools. These tools enable life scientists to analyse components of living cells at the molecular level, which is essential in understanding health and disease. Headquartered in Cambridge (UK), Abcam has subsidiary offices in Bristol (UK), Cambridge, MA (USA), Eugene, OR (USA), San Francisco, CA (USA), Tokyo (Japan), Hangzhou and Hong Kong (both in China), allowing it to serve a global customer base in over 130 countries. Abcam employs over 600 staff across its eight operating companies. Abcam now has an online catalogue of over 98,500 products sourced from over 400 suppliers. The catalogue includes a growing range of non-primary antibody products such as secondaries, proteins, peptides, lysates, immunoassays and other kits. Products are available for life science research and distributed to academic and commercial users. A highly developed eCommerce platform, which includes regional websites for the Chinese and Japanese markets, allows customers to access up-to-date and detailed technical product data sheets at the Company's website www.abcam.com. Abcam was admitted to AIM in November 2005 and trades under the ticker symbol ABC. The Company's vision is to be the world's leading life science tools company. This information is provided by RNS The company news service from the London Stock Exchange END TVRUGGAAGUPPGQG -0- Nov/01/2012 16:56 GMT
ABCAM Plc ABC Total Voting Rights
Press spacebar to pause and continue. Press esc to stop.